Physician profile
Robyn Brown
NPI 1700055845
$914.54
in general payments reported to CMS, 2019-2025
16 companies · $25.00 in 2025
The $25.00 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $195 · 2023: $479 · 2024: $216 · 2025: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $135.25 | 2022-2024 | Jynarque |
| Novartis Pharmaceuticals Corporation | $132.61 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.47 | 2022-2024 | |
| Fresenius USA Marketing, INC. | $83.47 | 2023 | Velphoro, Korsuva |
| Calliditas Therapeutics US INC. | $65.49 | 2022-2023 | Tarpeyo |
| Astrazeneca Pharmaceuticals Lp | $63.41 | 2022-2023 | Lokelma, Farxiga |
| Vifor Pharma, INC. | $63.17 | 2023-2024 | Veltassa |
| Boston Scientific Corporation | $58.35 | 2024 | Watchman Flx |
| Opko Pharmaceuticals, LLC | $43.49 | 2023 | Rayaldee |
| Vantive US Healthcare LLC | $25.00 | 2025 | Renal - Pd |
| Recor Medical INC | $24.35 | 2024 | Paradise Renal Denervation System |
| Mallinckrodt Hospital Products INC. | $22.77 | 2023 | Acthar |
| Horizon Therapeutics Plc | $19.60 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.84 | 2022 | |
| Novo Nordisk INC | $16.05 | 2023 | Ozempic |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $14.22 | 2023 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.